3D Medicines (HKSE:01244) Other Operating Expense : HK$-15.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines Other Operating Expense?

3D Medicines's Other Operating Expense for the six months ended in Dec. 2023 was HK$-10.3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-15.5 Mil.

3D Medicines's quarterly Other Operating Expense declined from Dec. 2022 (HK$-4.5 Mil) to Jun. 2023 (HK$-5.2 Mil) and declined from Jun. 2023 (HK$-5.2 Mil) to Dec. 2023 (HK$-10.3 Mil).

3D Medicines's annual Other Operating Expense increased from Dec. 2021 (HK$-10.3 Mil) to Dec. 2022 (HK$-5.4 Mil) but then declined from Dec. 2022 (HK$-5.4 Mil) to Dec. 2023 (HK$-15.5 Mil).

3D Medicines Other Operating Expense Historical Data

The historical data trend for 3D Medicines's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines Other Operating Expense Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

14.68

-10.31

-5.37

-15.46

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial			-	-0.96	-4.46	-5.17	-10.30

3D Medicines Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-15.5 Mil.

3D Medicines Other Operating Expense Related Terms

Thank you for viewing the detailed overview of 3D Medicines's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

Executives

Gong Zhaolong	2101 Beneficial owner
Zhu Pai	2101 Beneficial owner
Dragon Prosper Holdings Limited	2101 Beneficial owner
Simcere Pharmaceutical Group Limited	2101 Beneficial owner
Gong Zhaolong	2501 Other
Immunal Medixin Us Limited	2101 Beneficial owner
Kastle Limited
Shanghai Zhenlu Enterprise Management Consulting Partnership (limited Partnership)	2101 Beneficial owner
Shenzhen Efung Holding Co., Ltd.	2201 Interest of corporation controlled by you
Shenzhen Efung Investment Management Enterprise (l.p.)	2201 Interest of corporation controlled by you
Shenzhen Efung Ruishi Investment Enterprise (limited Partnership)	2201 Interest of corporation controlled by you
Zhu Jinqiao	2103 Interests held jointly with another person

3D Medicines (HKSE:01244) Headlines

No Headlines